Immortalisation of Human Antibody Producing Cells

References

• Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–497
   PubMed Web of Science ®Google Scholar
• Littlefield JW. Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinations. Science 1964; 145: 709–710
   PubMed Web of Science ®Google Scholar
• Pontecorvo G. Production of indefinitely mutliplying mammalian somati cell hybrids by polyethylene glycol (PEG) treatment. Somatic Cell Genet 1976; 1: 397–400
   Google Scholar
• Galfrè G, Have S C, Milstein C, Butcher G W, Howard JC. Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 1977; 266: 550–552
   PubMed Web of Science ®Google Scholar
• Shulman M, Wilde C D, Köhler G. A better cell line for making hybridomas secreting specific antibodies. Nature 1978; 276: 269–270
   PubMed Web of Science ®Google Scholar
• Kearney J F, Redbruch A, Liesegang B, Rajewsky K. A new myeloma cell line which has lost immunoglobulin expression but permits the construction of antibody in secreting hybrid cell lines. J Immunol 1979; 123: 1548–1550
   PubMed Web of Science ®Google Scholar
• Galfrè G, Milstein C. Preparation of monoclonal antibodies strategies and procedures. Meth Enzymol 1981; 73: 3–46
   PubMedGoogle Scholar
• Effros R B, Hulette C M, Ettenger R, Dillard L C, Zeller E, Duang R, Walford RL. A human-human hybridoma secreting anti-HLA class II antibody. J Immunol 1986; 137: 1599–1603
   Google Scholar
• Schlom J, Wunderlich D, Teramoto Y. A generation of human monoclonal antibodies reactive with mammary carcinoma cells. Proc Natl Acad Sci USA 1980; 77: 6841–6845
   PubMed Web of Science ®Google Scholar
• Shawler D L, Bartholomew R M, Smith L M, Dillman RA. Human immune response to multiple injections of murine monoclonal IgG. J Immunol 1985; 135: 1530–1535
   PubMed Web of Science ®Google Scholar
• Larrick J W, Bourla JM. Prospects for the therapeutic use of human monoclonal antibodies. J Biol Rex Mod 1986; 5: 379–393
   PubMedGoogle Scholar
• Borrebaeck C AK. Strategy for the production of human monoclonal antibodies using in vitro activated B cells. J Immunol Methods 1989; 123: 157–165
   PubMed Web of Science ®Google Scholar
• Casali P, Notkins AL. Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Ann Rev Immunol 1989; 7: 513–535
   PubMed Web of Science ®Google Scholar
• Iscnberg D A, Shoenfeld Y, Schwartz RS. The use of hybridomas to analyse autoimmunity. Br Med Bull 1984; 40: 262–266
   Google Scholar
• Nakemura M, Burastero S, Ukei Y, Larrick J, Notkins A L, Casali P. Proving the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus. J Immunol 1988; 141: 4165–4172
   Google Scholar
• James K. Human monoclonal antibody technology—are its achievements, challenges and potential appreciated. Scand J Immunol 1989; 29: 257–264
   Google Scholar
• Rauch J, Massicotte H, Tannenbaum HT. Hybridoma anti-DNA autoantibodies from patients with rheumatoid arthritis and systemic lupus erythematosus demonstrate similar nucleic acid binding characteristics. J Immunol 1985; 134: 180–186
   PubMed Web of Science ®Google Scholar
• Brown C MS, Plater-Zyberk C, Mageed R A, Jefferis R, Maini RN. Analysis of immunoglobulins secreted by hybridomas derived from rheumatoid synovia. Clin Exp Immunol. 1990; 80: 366–372
   PubMedGoogle Scholar
• Shoenfeld Y, Rauch J, Massicotte H, Datta S K, Andre-Schwartz J, Stollar B D, Schwartz RS. Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. New Engl J Med 1983; 308: 414–420
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Isenberg D A, Rauch J, Madaio M, Stollar B D, Schwartz RS. Idiotypic cross reactions of monoclonal human lupus autoantibodies. J Exp Med 1983; 158: 718–730
   PubMed Web of Science ®Google Scholar
• Cairns E, Kwong P C, Misener V, Ip P, Bell D A, Siminovitch K. Analysis of variable region genes encoding a human anti-DNA antibody of normal origin. J Immunol 1989; 143: 685–691
   PubMedGoogle Scholar
• Logtenberg T, Young F M, Van Es J H, Gmelig-Meyling F HJ, Alt FW. Autoantibodies encoded by the most JH-proximal human immunoglobulin heavy chain variable region gene. J Exp Med 1989; 170: 1347–1355
   PubMed Web of Science ®Google Scholar
• Van Es J H, Gmelig-Meyling F HJ, Van de Akker W RM, Logtenberg T. Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. J Exp Med 1991; 173: 461–470
   PubMed Web of Science ®Google Scholar
• Manheimer-Levy A J, Davidson A, Watkins D, Hannigan N R, Diamond BA. Generation and analysis of clonal IgM-and IgG-producing human B cell lines expressing an anti-DNA-associated idiotype. J Clin Invest 1991; 87: 1519–1525
   Google Scholar
• James K, Bell GT. Human monoclonal antibody production. Current status and future prospects. J Immunol Methods 1987; 100: 5–40
   PubMed Web of Science ®Google Scholar
• Kozbor D, Roder JC. In vitro stimulated lymphocytes as a source of human hybridomas. Eur J Immunol 1984; 14: 23–27
   Google Scholar
• Stevens R H, Macy E, Morrow C, Sarom A. Characterisation of a circulating subpopulation of spontaneous anti-tetanus toxoid antibody producing B cells following in vitro booster immunization. J Immunol 1979; 122: 2498–2504
   PubMed Web of Science ®Google Scholar
• Watts R A, Winska-Wiloch H, Muller S, Isenberg DA. Analysis of factors affecting human hybridoma production. Hum. Antibodies Hybridomas 1990; 1: 160–165
   Google Scholar
• Winger L, Winger C, Shastry P, Russell A, Longinecker M. Efficient generation in vitro from human peripheral blood cells of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization. Immunology 1983; 80: 4484–4488
   Google Scholar
• Steinitiz M, Koskimies S, Klein G, Mäkelä O. Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV) transformation. J Clin Lab Immunol 1979; 2: 1–7
   Google Scholar
• Doyle A, Jones T J, Bidwell J L, Bradley BA. In vitro development of human monoclonal antibody secreting plasmacytomas. Human Immunol 1985; 13: 199–209
   Google Scholar
• Kozbor D, Roder JC. Requirements for the establishment of high-titred human monoclonal antibodies against tetanus tox-oid using the Epstein-Barr virus technique. J Immunol 1981; 127: 1275–1280
   PubMed Web of Science ®Google Scholar
• Boyd J E, James K, McLelland D BL. Human monoclonal antibodies—production and potential. Trends in Biotechnol 1984; 2: 70–72
   Google Scholar
• Gigliotti F, Smith L, Insel RA. Reproducible production of protective human monoclonal antibodies by fusion of peripheral blood lymphocytes with a mouse myeloma cell line. J Infect Dis 1984; 149: 43–47
   Google Scholar
• Teng N NH, Kaplan H S, Herbert J M, Moore C, Douglas H, Wunderlich A, Braude Al. Protection against gram-negative bacteremia and endotoxemia with human monoclonal antibodies. Proc Nail Acad Sci USA 1985; 82: 1790–1794
   PubMed Web of Science ®Google Scholar
• Wasserman R L, Budens R D, Thaxton ES. in vitro stimulation prior to fusion generates antigen-binding human-human hybridomas. J Immunol Methods 1986; 93: 275–283
   Google Scholar
• Denis K A, Wall R, Saxton A. Human-human cell hybridomas from in vitro stimulated lymphocytes of patients with common variable immunodeficiency. J Immunol 1983; 131: 2273–2278
   Google Scholar
• Ho M-K, Rand N, Murray J, Kato K, Rabin H. In vitro immunisation of human lymphocytes. 1. Production of human monoclonal antibodies against bombesin and tetanus toxoid. J Immunol 1985; 135: 3831–3838
   Google Scholar
• Shoenfeld Y, Hsu-Lin S C, Gabriels J E, Silbertsein L E, Furie B C, Furie B, Stollar B D, Schwartz RS. Production of autoantibodies by human-human hybridomas. J Clin Invest 1982; 70: 205–208
   PubMed Web of Science ®Google Scholar
• Astaldi G CB, Wright E P, Willems C H, Zeijlemaker W P, Janssen MC. Increase of hybridoma formation by human lymphocytes after stimulation in vitro. Effect of antigen, endothelial cells and PWM. J Immunol 1982; 128: 2539–2542
   PubMedGoogle Scholar
• Matsumoto Y, Sugano T, Miyamoto C, Masuho Y. Generation of hybridomas producing human monoclonal antibodies against human cytomegalovirus. Biochem Biophys Res Commitn 1986; 137: 273–280
   Google Scholar
• Borrebaeck C AK, Danielssen L, Möller SA. Human monoclonal antibodies produced from L-leucine methyl estertreated and in vitro immunized peripheral blood lymphocytes. Biochem Biophys Res Commun 1987; 148: 941–946
   Google Scholar
• Borrebaeck C AK, Danielssen L, Möller SA. Human monoclonal antibodies produced by primary in vitro immunization of peripheral blood lymphocytes. Proc Natl Acad Sci USA 1988; 85: 3995–3999
   PubMed Web of Science ®Google Scholar
• Ohlin M, Danielsson L, Carlsson R, Borrebaeck C AK. The effect of leucyl-leucine methyl ester on proliferation and Ig-secretion of EBV-transformed human lymphocytes. Immunol 1989; 66: 485–490
   Google Scholar
• Thiele D L, Lipsky PE. The immunosuppressive activity of L-leucyl-1-leucine methyl ester. Selective ablation of cytotoxic lymphocytes and monocytes. J Immunol 1986; 136: 1038–1048
   PubMed Web of Science ®Google Scholar
• Ohlin M, Broliden P A, Danielsson L, Wahren B, Rosen J, Jondal M, Borrebaeck C AK. Human monoclonal antibodies against a rcombinant HIV envelope-antigen produced by primary in vitro immunisation. Characterization and epitope mapping. Immunol 1989; 68: 325–331
   PubMed Web of Science ®Google Scholar
• Jelinek DF. Lipsky PE. Regulation of human B lymphocyte activation proliferation and differentiation. Adv Immunol 1987; 40: 1–59
   PubMed Web of Science ®Google Scholar
• Danielsson L, Möller SA, Borrebaeck C AK. Effect of cytokines on specific in vitro immunization of human peripheral B lymphocytes against T-cell dependent antigens. Immunol 1987; 61: 51–55
   Google Scholar
• Brodeur B R, Lagace L, Larose Y, Martin M, Joly J, Page M. Mouse-human myeloma partner for the production of heterohybridomas. Monoclonal Antibodies, B. Schook. Marcel Dekker, New York 1987; 51–63
   Google Scholar
• Strike L E, Devens B H, Lundak RC. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunisation. J Immunol 1984; 132: 1798–1803
   Google Scholar
• Ichimori Y, Sasano K, Itoh H, Hitosumachi S, Kimura Y, Kaneko K, Kida M, Tsakumoto K. Establishment of hybridomas secreting human monoclonal antibodies against tetanus toxin and hepatitis B virus surface antigen. Biochem Biophys Res Commun 1985; 129: 26–33
   PubMed Web of Science ®Google Scholar
• Teng N NH, Reyes G R, Bieber M, Fry K E, Lam K S, Herbert JM. Strategies for stable human monoclonal antibody production: Construction of heteromyelomas, in vitro sensitization and molecular cloning of human immunoglobulin genes. Human Hybridomas and Monoclonal Antibodies, EG Engleman, SKH Foung, J Larrick, A. Raubitschek. Plenum Press, New York 1985; 71
   Google Scholar
• Olsson L, Kaplan HS. Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci USA 1980; 77: 5429–5431
   PubMed Web of Science ®Google Scholar
• Nilsson K, Bennich H, Johansson S GO, Ponten J. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp Immunol 1970; 7: 477–489
   PubMed Web of Science ®Google Scholar
• Croce C, Linnenbach A, Hall W, Stcplewski Z, Koprowski H. Production of human hybridomas secreting antibodies to measles virus. Nature 1980; 288: 488–489
   PubMed Web of Science ®Google Scholar
• Hunter KW, Jr., Fisher G W, Hemming V G, Wilson SR. Amibacterial activity of a human monoclonal antibody to Haemophilus influenzae type B capsular polysaccharide. Lancet 1982; ii: 798–799
   Google Scholar
• Larrick J W, Truitt K E, Raubitschek A A, Senyk G, Wang J CN. Characterisation of human hybridomas secreting antibody to tetanus toxoid. Proc Natl Acad SCi USA 1983; 80: 6376–6380
   PubMed Web of Science ®Google Scholar
• Ritts R E, Ruiz-Arguelles A, Weyl K G, Bradley A L, Weiheimer B, Jacobsen D J, Strehlo BL. Establishment and characterisation of a human non-secreting plasmacytoid cell line and its hybridisation with human B cells. Int J Cancer 1983; 31: 133–141
   Google Scholar
• Lowe A D, Green S M, Voak D, Gibson T, Lennox ES. A human-human monoclonal anti-D by direct fusion with a lymphoid line. Vox Sang 1986; 51: 212–216
   Google Scholar
• Olsson L, Andreasen R B, Ost A, Christensen B, Biberfeld P. Antibody producing human-human hybridonias II. Derivation and characterization of an antibody specific for human leukaemia cells. J Exp Med 1984; 159: 537–550
   PubMed Web of Science ®Google Scholar
• Warcnius H M, Taylor J W, Durack B E, Cross PA. The production of human hybridomas from patients with malignant melanoma. The effect of prestimulation of lymphocytes with pokeweed mitogen. Eur J Cancer Clin Oncol 1983; 19: 347–355
   Google Scholar
• Eisenbarth G A, Linnenbach A, Jackson R, Scarce R, Croce CM. Human hybridomas secreting anti-islet autoantibodies. Nature 1982; 300: 264–267
   Google Scholar
• Burnett K G, Leung J P, Martinis J. Human monoclonal antibodies to defined antigens. Towards clinical applications. Human Hybridomas and Monoclonal Antibodies, EG Engelman, SKH Foung, J Larrick, A. Raubitschek. Plenum Press, New York 1985; 113
   Google Scholar
• Lowe D H, Handley H H, Schmidt J, Royston 1, Glassy M. A human monoclonal antibody reactive with human prostate. J Virol 1984; 132: 780–785
   Google Scholar
• Valente W A, Vitti P, Yavin Z, Yavin E, Rotella C M, Grollman E F, Toecafondi R S, Kohn LD. Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves' disease. Proc Natl Acad Sci USA 1982; 79: 6680–6684
   PubMed Web of Science ®Google Scholar
• Jahn S, Setlmacher V, Hansel K, Kiessig St. Grunow R, von Baehr R. Development of specific IgG-producing human hybridomas by fusions of lymphocytes from actively immunised persons. Hybridoma 1989; 8: 529–533
   Google Scholar
• Ostberg L, Pursch E. Human X (mouse X human) hybridomas stably producing human antibodies. Hybridoma 1983; 2: 361–367
   PubMed Web of Science ®Google Scholar
• Bron D, Feinberg M B, Teng N NH, Kaplan HS. Production of human monoclonal IgG antibodies against rhesus (D) antigen. Proc Natl Acad Sci USA 1984; 81: 3214–3217
   PubMed Web of Science ®Google Scholar
• Winkler T H, Jahn S, Kalden JR. IgG human anli-DNA autoantibodies from patients with syslemic lupus erythematosus. Clin Exp Immunol 1991, In Press
   Google Scholar
• Logtenberg T, Kroon A, Gmelig-Meyling F HJ, Ballicux RE. Analysis of the human tonsil B cell repertoire by somatic hybridisation: Occurrence of both ‘monospecific’ and ‘multispecific’ (auto)-antibody secreting cells. Eur J Immunol 1987; 17: 855–859
   PubMedGoogle Scholar
• Teng N NH, Lam K S, Riera F C, Kaplan HS. Construction and testing of mouse-human heteromyelomas for human monoclonal antibody production. Proc Natl Acad Sci USA 1983; 80: 7308–7312
   PubMed Web of Science ®Google Scholar
• Abrams P G, Knost J A, Clarke G, Wilburn S, Oldham R K, Foon KA. Determination of the optimal human cell lines for development of human hybridomas. J Immunol 1983; 131: 1201–1204
   PubMed Web of Science ®Google Scholar
• Jernberg H, Bjorklund G, Nilsson K. Establishment of a new human myeloma cell line (U-2030) and selection of a HAT-sensitive subline. Int J Cancer 1987; 39: 745–751
   PubMedGoogle Scholar
• Kozbor D, Lagarde A E, Roder JC. Human hybridomas constructed antigen specific Epstein-Barr virus-transformed cell lines. Proc Natl Acad Sci USA 1982; 79: 6651–6655
   PubMed Web of Science ®Google Scholar
• Hulette C M, Effros R B, Dillard L C, Walford RL. Production of a human monoclonal antibody to HLA by human-human hybridoma technology. A preliminary report. Am J Pathol 1985; 121: 10–14
   Google Scholar
• Edwards P AW, Smith C M, Neville A M, O'Hare MJ. A human-human hybridoma system based on a fast growing mutant of ARH-77 plasma cell leukemia-derived line. Eur J Immunol 1982; 12: 641–648
   PubMedGoogle Scholar
• Chiorazzi N, Wasserman R L, Kunkel HG. Use of Epstein—Barr virus-transformed B cell lines for the generation of immunoglobulin producing human B cell hybridomas. J Exp Med 1982; 156: 930–935
   PubMed Web of Science ®Google Scholar
• Glassy M C, Handley H H, Hagiwara H, Royston I. UC729–6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas. Proc Natl Acad Sci USA 1983; 80: 6327–6331
   PubMed Web of Science ®Google Scholar
• Ichimori Y, Harada K, Hitosumachi S, Tsukamoto K. Establishment of hybridoma secreting human monoclonal antibody against Hepatitis B virus surface antigen. Biochem Biophys Rex Commun 1987; 142: 805–812
   Google Scholar
• Ohashi H, Hashizume S, Murakami H, Aihara K, Shinohara K. Omura?. Ho-323, a human B-lymphoid cell line useful for making human-human hybridomas. Cell Biol Int Rep 1986; 10: 77–83
   Google Scholar
• Posner M R, Schlossman S F, Lazarus H. Novel approach to construction of human myeloma analogues for production of human monoclonal antibodies. Hybridoma 1983; 2: 369–381
   Google Scholar
• Foung S KH, Perkins S, Arvin A, Lifson J, Mohagheghpour N, Fishwild D, Grumet F C, Engleman EG. Production of human monoclonal antibodies using a human mouse fusion partner. Human Hybridomas and Monoclonal Antibodies, EG Engelman, SKH Foung, J Larrick, A. Raubitschek. Plenum Press, New York 1985; 135
   Google Scholar
• Pollack M, Raubitschek A A, Larrick JW. Human monoclonal antibodies that recognize conserved epitopes in the core lipid A region of lipopolysaccharides. J Clin Invest 1987; 79: 1421–1430
   PubMedGoogle Scholar
• Grunow R, Jahn S, Porstmann T, Keissig S S, Steinkellner H. Steindl F, Mattanovich D, Gurtler L, Deinhardt F, Katinger H, von Baehr R. The high efficiency, human B cell immortalising heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus. J Immunol Methods 1988; 106: 257–265
   PubMed Web of Science ®Google Scholar
• Nilsson K, Ponten L. Classification and biological nature of established human hematopoietic cell lines. Int J Cancer 1975; 15: 321–341
   PubMed Web of Science ®Google Scholar
• Reedman B M, Klein G. Cellular localization of an Epstein—Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 1973; 11: 499–520
   PubMed Web of Science ®Google Scholar
• Abrahms P G, Ochs J J, Giardina A C, Morgan S B, Wilburn A, Wilt R, Oldham R K, Foon KA. Production of large quantities of human immunoglobulin in the asciles of alhymic mice: Implications for the development of anti-human idiotype monoclonal antibodies. J Immunol 1984; 132: 1611–1613
   Google Scholar
• Erikson J, Martinis J, Croce CM. Assignment of the genes for human lambda immunoglobulin chains to chromosome 22. Nature 1981; 294: 173–175
   PubMed Web of Science ®Google Scholar
• Kozbor D, Roder JC. The production of monoclonal antibodies from human lymphocytes. Immunol Today 1983; 4: 72–79
   Google Scholar
• Shander M, Martinis J, Croce CM. Genetics of human immunoglobulins: assignment of the genes for mu, alpha and gamma immunoglobulin chains to human chromosome 17. Transplant Proc 1980; 12: 417–420
   PubMedGoogle Scholar
• Sikora K, Wright R. Human monoclonal antibodies to lung cancer antigens. Br J Cancer 1981; 43: 696–700
   PubMed Web of Science ®Google Scholar
• Raison R L, Walker K Z, Hainan C RE, Biscoe D, Basten A. Loss of secretion in mouse-human hybrids need not be due to the loss of a structural gene. J Exp Med 1982; 156: 1380–1389
   PubMed Web of Science ®Google Scholar
• Epstein M A, Achong BG. The relationship of the virus with Burkitt's lymphoma. The Epstein-Barr Virus, MA Epslein, BG Achong. Springer, Berlin 1979; 321–327
   Google Scholar
• Epstein MA. Epstein-Barr virus—discovery properties and relationship to nasopharyngeal carcinoma. Nasopharyngeal Carcinoma, Aetiology and Control, Y Ho, W Davis. IARC, Lyon 1978; 333–345
   Google Scholar
• Henle G, Henle W, Diehl V. Relation of Burkitt's tumour-associated herpes-types virus to infectious mononucleosis. Proc Natl Acad Sci USA 1968; 59: 94–101
   PubMed Web of Science ®Google Scholar
• Pattengale P K, Smith R W, Berber P. Selective transformation of B lymphocytes by EB virus. Lancet 1973; ii: 93–94
   Google Scholar
• Rosen A, Gergely P, Jondal M, Klein G, Britton S. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes. in vitro. Nature 1977; 267: 52–54
   PubMed Web of Science ®Google Scholar
• Miller G, Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 1973; 70: 190–194
   PubMed Web of Science ®Google Scholar
• Nemerow G R, Wolfert R, McNaughton M E, Cooper NR. Identification and characterisation of the EBV receptor on human B lymphocytes and its relationship to the C3d complement receptor (Cr2). J Virol 1985; 55: 347–351
   PubMed Web of Science ®Google Scholar
• Yarchoan R, Tosato G, Blaese M R, Simon R K, Nelson DL. Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production by human B cells. J Exp Med 1983; 157: 1–14
   Google Scholar
• Tosato G, Blaese M R, Yarchoan R. Relationship between immunoglobulin production and immortalisation by Epstein—Barr virus. J Immunol 1985; 135: 959–964
   PubMed Web of Science ®Google Scholar
• Chan M A, Stein L D, Dosch H-M, Sigal NH. Heterogeneity of EBV-transformable human B lymphocyte populations. J Immunol 1986; 136: 106–112
   PubMed Web of Science ®Google Scholar
• Steinitz M, Klein G, Koskimies S, Mäkelä O. EB virus-induced B lymphocyte cell lines producing specific antibody. Nature 1977; 269: 420–422
   PubMed Web of Science ®Google Scholar
• Koskimies S. Human lymphoblastoid cell line producing antibody against Rh antigen D. Scand J Immunol 1980; 11: 73–77
   Google Scholar
• Kozbor D, Steinitz M, Klein G, Koskimies S, Mäkelä O. Establishment of anti-TNP antibody-producing human lymphoid lines by preselection for hapten binding followed by EBV transformation. Scand J Immunol 1979; 10: 187–194
   Google Scholar
• Zurawski V R, Jr., Haber E, Black PM. Production of antibody to tetanus toxoid by continuous human lymphoblastoid cell lines. Science 1978; 199: 1439–1441
   PubMedGoogle Scholar
• Tsuchiya S, Yokoyama S, Yoshie O, Ono Y. Production of diphtheria antitoxin antibody in Epstein-Barr virus-induced lymphoblastoid cell lines. J Immunol 1980; 124: 1970–1974
   Google Scholar
• Rosen A, Persson K, Klein G. Human monoclonal antibodies to a genus specific chlamydial antigen, produced by EBV-transformed B cells. J Immunol 1983; 130: 2899–2902
   PubMed Web of Science ®Google Scholar
• Crawford D H, Callard R E, Muggeridge M I, Mitchell D M, Zanders E D, Beverly P CL. Production of human monoclonal antibody to X31 influenza virus nucleoprotein. J Gen Virol 1983; 64: 697–700
   Google Scholar
• Evans L, Maragos C, May JT. Human lymphoblastoid cell lines established from peripheral blood lymphocytes secreting immunoglobulins directed against herpes simplex virus. Immunol Lett 1984; 8: 39–42
   Google Scholar
• Redmond M J, Levritz-Wills M, Winger, Scraba DG. The selection and characterization of human monoclonal antibodies to human cylomegalovirus. J Virol Methods 1986; 14: 9–24
   Google Scholar
• Goosens D, Champomier F, Rouger P, Salmon C. Human monoclonal antibodies against blood group antigens: Preparation of a series of stable EBV immortalized clones producing high levels of antibody of different isotypes and specificities. J Immunol Methods 1987; 101: 193–200
   Google Scholar
• Crawford D H, Barlow M J, Harrison J F, Winger L, Huehns ER. Production of human monoclonal antibody to rhesus D antigen. Lancet 1983; i: 386–388
   Google Scholar
• Watson D B, Burns G F, Mackay IR. In vitro growth of B lymphocytes infiltrating human melanoma tissue by transformation with EBV: evidence for secretion of antimelanoma antibodies by some transformed cells. J Immunol 1983; 130: 2442–2447
   PubMed Web of Science ®Google Scholar
• Al-Azzawi F, Stimson W H, Goven A DT. Human antibodies to ovarian cancer antigens secreted by lymphoblastoid cell lines. J Clin Lab Immunol 1987; 22: 71–75
   Google Scholar
• Kamo I, Furukawa S, Tada A, Mano Y, Iwasaki Y, Furuse T, Ito N, Hayashi K, Satayoshi E. Monoclonal antibody to acetylcholine receptor: cell line established from thymus of patient with myasthenia gravis. Science 1982; 215: 995–997
   PubMed Web of Science ®Google Scholar
• Steinitz M, Izak G, Cohen S, Ehrenfeld M, Flechner I. Continuous production of monoclonal rheumatoid factor by EBV-transformed lymphocytes. Nature 1980; 287: 443–445
   PubMed Web of Science ®Google Scholar
• Melamed M D, Gordon J, Ley S J, Edgar D, Hugh-Jones NC. Senescence of a human lymphoblastoid clone producing anti-Rhesus (D). Eur J Immunol 1985; 15: 742–746
   Google Scholar
• Stein L D, Sigal NH. Limiting dilution analysis of Epstein Barr virus induced immunoglobulin production. Cell Immunol 1983; 79: 309–319
   Google Scholar
• Aman P, Gordon J, Lewin N, Nordstrom M, Ehlin-Henriksson B, Klein G, Carstensson A. Surface marker characteristics of EBV target cells in normal blood and tonsil B lymphocyte populations. J Immunol 1985; 135: 2362–2367
   Google Scholar
• Inghirami G, Nakamura M, Balow J E, Notkins H L, Casali P. Model for studying virus attachment: Identification and quantitation of Epstein-Barr virus-binding cells by using biotinylated virus in flow cytometry. J Virol 1988; 62: 2453–2463
   PubMedGoogle Scholar
• Martinez-Maza O, Britton S. Frequencies of the separate human B subsets activatable to Ig secretion by Epstein-Barr virus and pokeweed mitogen. J Exp Med 1983; 157: 1808–1814
   Google Scholar
• Kozbor D, Roder J C, Chang T H, Steplewski Z, Koprowsky H. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cell fused with a murine myeloma. Hybridoma 1982; 1: 323–328
   PubMed Web of Science ®Google Scholar
• Haskard D O, Archer JR. The production of human monoclonal autoantibodies from patients with rheumatoid arthritis by the EBV-hybridoma technique. J Immunol Methods 1984; 74: 361–367
   Google Scholar
• Atlaw T, Kozbor D, Roder JC. Human monoclonal antibodies against Mycobacterium leprae. Infect Immun 1985; 49: 104–110
   Google Scholar
• Tiebout R F, Strieker E AM, Oosterhof F, Van Heemston D JM, Zeijlemaker WP. Xenohybridisation of Epstein-Barr virustransformed cells for the production of human monoclonal antibodies. Scand J Immunol 1985; 22: 691–701
   PubMedGoogle Scholar
• Larrick J W, Dyer B J, Senyk G, Hart S M, Moss R, Lippman D, Jahnsen M C, Wang J, Weintraub H, Raubitschek AA. In vitro expansion of human B cells for the production of human monoclonal antibodies. Human Hybridomas and Monoclonal Antibodies, EG Engelman, SKH Foung, J. Larrick, A. Raubitschek. Plenum Press, New York 1985; 149
   Google Scholar
• Garzelli C, Puglisi C, Falcone G. Human monoclonal antibody to purified protein derivative of tuberlin produced by the hybrids constructed with Epstein-Barr virus transformed B lymphocytes and mouse myeloma cells. Eur J Immunol 1986; 16: 584–587
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Furukawa K, Fortunato S R, Livingston P O, Lloyd K O, Oettgen H F, Old LJ. Cell surface antigens of melanoma recognized by human monoclonal antibodies. Proc Natl Acad Sci USA 1987; 84: 2416–2420
   PubMed Web of Science ®Google Scholar
• Foung S KH, Blunt J, Perkins J, Winn L, Grumet FC. A human monoclonal antibody to Rh.G. Vox Sang 1986; 50: 160–163
   Google Scholar
• Foung S KH, Blunt J, Wu P S, Ahearn P, Winn L, Engelman EG. Human monoclonal antibodies to Rh O (D). Vox Sang 1987; 53: 44–47
   Google Scholar
• Alpert S D, Turek P J, Foung S KH, Engelman EG. Human monoclonal anti-T cell antibody from a patient with juvenile rheumatoid arthritis. J Immunol 1987; 138: 104–108
   Google Scholar
• Morrison S L, Johnson M J, Herzenberg L A, Oi VT. Chimeric human antibody molecules. Mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci USA 1984; 81: 6851–6855
   PubMed Web of Science ®Google Scholar
• Neuberger M S, Williams G T, Mitchell E B, Jouhal S S, Flanaghan J G, Rabbits TH. A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature 1985; 314: 268–270
   PubMed Web of Science ®Google Scholar
• Bruggeman M, Williams G T, Binden C I, Clark M R, Walker M R, Jefferis R, Waldman H, Neuberger M. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 1987; 166: 1351–1361
   PubMed Web of Science ®Google Scholar
• Roberts S, Cheetham J C, Rees AR. Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering. Nature 1987; 328: 731–734
   PubMed Web of Science ®Google Scholar
• Reichmann L, Clark M, Waldman H, Winter G. Reshaping human antibodies for therapy. Nature 1988; 332: 323–327
   PubMed Web of Science ®Google Scholar
• Orlandi R, Güssaw DH, Jones P T, Winter G. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 3833–3837
   PubMed Web of Science ®Google Scholar
• Sastry L, Alting-Mees M, Huse W, Short J M, Sorge J A, Hay B N, Janda K D, Benkovic S J, Lerner RA. Cloning of the immunological repertoire in Escherichia coli for the generation of monoclonal catalytic antibodies: Construction of a heavy chain variable region-specific cDNA library. Proc Natl Acad Sci USA 1989; 86: 5728–5732
   PubMed Web of Science ®Google Scholar
• Huse W D, Sastry L, Iverson S A, Kang A S, Alting-Mees M, Burton D R, Benkovic S J, Lerner RA. Generation of a large combinatorial library of immunoglobulin repertoire in phage lambda. Science 1989; 246: 1275–1281
   PubMed Web of Science ®Google Scholar
• Barbas I CF, II., Kang A S, Lerner R A, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: The gene III site. Proc Natl Acad Sci USA 1991; 88: 7978–7982
   PubMed Web of Science ®Google Scholar
• Lerner R A, Benkovic S J, Schultz PG. At the crossroads of chemistry and immunology: Catalytic antibodies. Science 1991; 252: 659–667
   PubMed Web of Science ®Google Scholar